Share on StockTwits
 

Analysts’ downgrades for Tuesday, January 21st:

Boise Cascade Company (NYSE:BCC) was downgraded by analysts at Zacks from an outperform rating to a neutral rating. The firm currently has $34.50 target price on the stock.

Cavium (NASDAQ:CAVM) was downgraded by analysts at Zacks from a neutral rating to an underperform rating. Zacks currently has $33.90 price target on the stock.

Celadon Group (NYSE:CGI) was downgraded by analysts at Zacks from a neutral rating to an underperform rating. They currently have $19.10 target price on the stock.

CryoLife (NYSE:CRY) was downgraded by analysts at Zacks from an outperform rating to a neutral rating. They currently have $12.40 price target on the stock.

Getty Realty Corp. (NYSE:GTY) was downgraded by analysts at Zacks from an outperform rating to a neutral rating. They currently have $22.40 target price on the stock.

Horizon Bancorp (Indiana) (NASDAQ:HBNC) was downgraded by analysts at Zacks from an outperform rating to a neutral rating. The firm currently has $27.70 price target on the stock.

K12 (NYSE:LRN) was downgraded by analysts at Zacks from a neutral rating to an underperform rating. They currently have $21.50 price target on the stock.

Old Line Bancshares (NASDAQ:OLBK) was downgraded by analysts at Zacks from a neutral rating to an underperform rating. They currently have $15.20 target price on the stock.

Qiwi PLC (NASDAQ:QIWI) was downgraded by analysts at Zacks from an outperform rating to a neutral rating. They currently have $48.00 target price on the stock.

Elizabeth Arden (NASDAQ:RDEN) was downgraded by analysts at Zacks from a neutral rating to an underperform rating. The firm currently has $26.60 price target on the stock.

Dr. Reddy’s Laboratories Limited (NYSE:RDY) was downgraded by analysts at Zacks from an outperform rating to a neutral rating. Zacks currently has $45.90 price target on the stock.

Taomee Holdings (NASDAQ:TAOM) was downgraded by analysts at Zacks from an outperform rating to a neutral rating. The firm currently has $8.30 price target on the stock.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.